Risk of cancer in Turkish patients after treatment with TNF antagonists

Rheumatology (Oxford). 2008 Apr;47(4):548-9. doi: 10.1093/rheumatology/ken026. Epub 2008 Feb 23.

Authors

S Pay; Society for Research and Education in Rheumatology of Turkey

Collaborators

Society for Research and Education in Rheumatology of Turkey:
M Akif Oztürk, Gerçek Can, Ayşe Cefle, Veli Cobankara, Burak Erer, Feride Göğüş, Gülen Hatemi, Nevsun Inanç, Yaşar Karaaslan, Omer Karadağ, Yüksel Karakoç, Esen Kasapoğlu Günal, Timuçin Kaşifoğlu, Gökhan Keser, Serdar Koca, Selda Oktem, Hüseyin T E Ozer, Mehmet Sayarlioğlu, Mehmet Soy, Taşkin Sentürk, Musa Temel, Ender Terzioğlu, Olcay Tiryaki, Tufan Türk, Eftal Yücel

PMID: 18296720
DOI: 10.1093/rheumatology/ken026

No abstract available

Publication types

Letter
Multicenter Study

MeSH terms

Adolescent
Adult
Antirheumatic Agents / adverse effects*
Arthritis / drug therapy*
Female
Humans
Male
Middle Aged
Neoplasms / chemically induced*
Risk Assessment
Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

Antirheumatic Agents
Tumor Necrosis Factor-alpha